Safety, Tolerability, and Pharmacokinetics of the Novel Adenosine A2A Antagonist/Inverse Agonist KW‐6356 Following Single and Multiple Oral Administration in Healthy Volunteers
暂无分享,去创建一个
Y. Kagawa | Yoshinori Nagata | M. Hruska | Tomonori Tayama | Masatake Ishiuchi | Kenichiro Sugiyama | Yuichi Oka | Hiroshi Maeda